Concepedia
Statistics
Publications
10
Citations
628
H-Index
Active since
1992
Affiliations
Eli Lilly (United States)(Current)
Eli Lilly (United Kingdom)
Ann Bond is an author at Eli Lilly (United States) specializing in medicine, neurology, and neuroscience.
Top concepts
MedicineNeurologyNeurosciencePharmacologyNeurophysiologyNeuropharmacologyNeurochemistrySocial SciencesNeuroprotectionPharmacotherapy
Publications per year
1992–2001
Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia
Michael J. O’Neill, Ann Bond, Paul L. Ornstein et al. · Neuropharmacology · 1998 · 115 citations
Global Cerebral Ischaemia, Neurophysiology, Medicine +14
NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus
Ann Bond, David Lodge, Caroline Hicks et al. · European Journal of Pharmacology · 1999 · 98 citations
Nmda Receptor Antagonism, Neurophysiology, Physiology +9
Neuroprotective effects of a systemically active Group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia
Ann Bond, Michael J. OʼNeill, Caroline Hicks et al. · Neuroreport · 1998 · 84 citations
Gerbil Model, Pharmacotherapy, Group Ii Mglurs +19
LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia
Ann Bond, Nella Ragumoorthy, James A. Monn et al. · Neuroscience Letters · 1999 · 77 citations
Medicine, Cerebral Ischaemia, Neuropharmacology +8
Stereoselective Effects of 2,3-benzodiazepines In Vivo : Electrophysiology and Neuroprotection Studies
David Lodge, Ann Bond, Michael J. O’Neill et al. · Neuropharmacology · 1996 · 69 citations
Neurophysiology, Medicine, Psychotropic Medication +13
1–5 of 10